Am J Obstet Gynecol
- SHIVRAJ P, Chadha R, Kincaid H, Sparks A, et al
Impact of the COVID-19 Pandemic on Fellowship Research.
Am J Obstet Gynecol. 2024 Feb 27:S0002-9378(24)00374.
Ann Intern Med
- PAULES CI, Wang J, Tomashek KM, Bonnett T, et al
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From
Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the
Adaptive COVID-19 Treatment Trial-2.
Ann Intern Med. 2024 Feb 27. doi: 10.7326/M23-2593.
Antiviral Res
- LI H, Sun M, Lei F, Liu J, et al
Methyl rosmarinate is an allosteric inhibitor of SARS-cov-2 3?C?L protease as a
potential candidate against SARS-cov-2 infection.
Antiviral Res. 2024 Feb 24:105841. doi: 10.1016/j.antiviral.2024.105841.
BMJ
- WISE J
Covid-19 taskforce called for a new national vaccine agency to prepare for future
pandemics.
BMJ. 2024;384:q534.
- BENTLEY-EDWARDS KL, Adisa O, Ruff KE, McClure ES, et al
Race, racism, and covid-19 in the US: lessons not learnt.
BMJ. 2024;384:e076106.
- WISE J
Covid-19: Two rare vaccine side effects detected in large global study.
BMJ. 2024;384:q488.
Clin Infect Dis
- SHAH MM, Joyce B, Plumb ID, Sahakian S, et al
Combined protection of vaccination and nirmatrelvir-ritonavir against
hospitalization in adults with COVID-19.
Clin Infect Dis. 2024 Feb 27:ciae105. doi: 10.1093.
- NIMGAONKAR I, Yoke LH, Roychoudhury P, Flaherty PW, et al
Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell
Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection.
Clin Infect Dis. 2024 Mar 1:ciae116. doi: 10.1093.
Emerg Infect Dis
- PATERSON A, Cheyne A, Jones B, Schilling S, et al
Systematic Review of Scales for Measuring Infectious Disease-Related Stigma.
Emerg Infect Dis. 2024;30:519-529.
- OGOTI BM, Riitho V, Wildemann J, Mutono N, et al
Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to
Humans, Kenya, 2022-2023.
Emerg Infect Dis. 2024;30:581-585.
- VU QM, Fitzpatrick AL, Cope JR, Bertolli J, et al
Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2
Infection.
Emerg Infect Dis. 2024;30:539-547.
- KECK JW, Adatorwovor R, Liversedge M, Mijotavich B, et al
Wastewater Surveillance for Identifying SARS-CoV-2 Infections in Long-Term Care
Facilities, Kentucky, USA, 2021-2022.
Emerg Infect Dis. 2024;30:530-538.
- VON MOLLENDORF C, Ulziibayar M, Nguyen CD, Batsaikhan P, et al
Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among
Children 2-59 Months of Age, Mongolia, 2015-2021.
Emerg Infect Dis. 2024;30:490-498.
Int J Infect Dis
- SYLVAIN L, Donatien K, Kadidia K, Viviane C, et al
SARS-CoV-2 seroprevalence in vaccine-naive participants from the Democratic
Republic of Congo, Guinea, Liberia, and Mali.
Int J Infect Dis. 2024 Feb 26:106985. doi: 10.1016/j.ijid.2024.106985.
- DADU A, Yedilbayev A, Migliori GB, Ahmedov S, et al
PASS to End TB in Europe: Accelerated efforts on Prevention and Systematic
Screening to End Tuberculosis in the WHO European Region by 2030.
Int J Infect Dis. 2024 Feb 23:S1201-9712(24)00051.
- FURST T, Bazalova A, Frycak T, Janosek J, et al
Does the healthy vaccinee bias rule them all? Association of COVID-19 vaccination
status and all cause mortality from an analysis of data from 2.2 million
individual health records.
Int J Infect Dis. 2024 Feb 22:S1201-9712(24)00046.
- HUANG L, Tong X, Cui J, Du X, et al
Recurrent and persistent fever after SARS-CoV-2 infection in patients with
follicular lymphoma: A case series.
Int J Infect Dis. 2024;141:106973.
- PETRAS M, Janovska D, Lomozova D, Franklova M, et al
Understanding the time-driven shifts of vaccine effectiveness against any and
severe COVID-19 before and after the surge of Omicron variants within 2.5 years
of vaccination: a meta-regression.
Int J Infect Dis. 2024 Feb 26:106986. doi: 10.1016/j.ijid.2024.106986.
J Med Virol
- WU P, Yii CY, Yong SB
Comment on "The risk assessment of uveitis after COVID-19 diagnosis".
J Med Virol. 2024;96:e29494.
- XIAO J, Luo Y, Li Y, Yao X, et al
The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2
vaccinated volunteers.
J Med Virol. 2024;96:e29488.
- ZHANG N, Ye Z, Li C, Zhou J, et al
A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent
protective immunity in BALB/c mice.
J Med Virol. 2024;96:e29479.
J Virol
- HE H, Li Y, Chen Y, Chen J, et al
NLRP1 restricts porcine deltacoronavirus infection via IL-11 inhibiting the
phosphorylation of the ERK signaling pathway.
J Virol. 2024 Feb 27:e0198223. doi: 10.1128/jvi.01982.
- MARTINS M, Nooruzzaman M, Cunningham JL, Ye C, et al
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the
attenuated phenotype of Omicron virus in a feline model of infection.
J Virol. 2024 Feb 29:e0190223. doi: 10.1128/jvi.01902.
JAMA
- ANDERSSON NW, Thiesson EM, Hviid A
Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
Lancet
- DHAIRYAWAN R
Candour, care, and COVID-19.
Lancet. 2024;403:718.
Lancet Infect Dis
- HANSEN CH, Moustsen-Helms IR, Rasmussen M, Soborg B, et al
Non-COVID-19 hospitalisation as a negative control outcome in COVID-19 vaccine
effectiveness studies - Authors' reply.
Lancet Infect Dis. 2024 Feb 22:S1473-3099(24)00107.
- POUKKA E, Auranen K, Baum U
Non-COVID-19 hospitalisation as a negative control outcome in COVID-19 vaccine
effectiveness studies.
Lancet Infect Dis. 2024 Feb 22:S1473-3099(24)00106.
Life Sci
- YOUSEF M, Rob M, Varghese S, Rao S, et al
The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative
and systematic review.
Life Sci. 2024;342:122535.
MMWR Morb Mortal Wkly Rep
- ESSER MB, Sherk A, Liu Y, Naimi TS, et al
Deaths from Excessive Alcohol Use - United States, 2016-2021.
MMWR Morb Mortal Wkly Rep. 2024;73:154-161.
- FRUTOS AM, Price AM, Harker E, Reeves EL, et al
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United
States.
MMWR Morb Mortal Wkly Rep. 2024;73:168-174.
- DECUIR J, Payne AB, Self WH, Rowley EAK, et al
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines
Against COVID-19-Associated Emergency Department and Urgent Care Encounters and
Hospitalization Among Immunocompetent Adults Aged >/=18 Years - VISION and IVY
Networks,
MMWR Morb Mortal Wkly Rep. 2024;73:180-188.
N Engl J Med
- HAMPSHIRE A, Azor A, Atchison C, Trender W, et al
Cognition and Memory after Covid-19 in a Large Community Sample.
N Engl J Med. 2024;390:806-818.
- AL-ALY Z, Rosen CJ
Long Covid and Impaired Cognition - More Evidence and More Work to Do.
N Engl J Med. 2024;390:858-860.
- ELLINGJORD-DALE M, Brunvoll SH, Soraas A
Prospective Memory Assessment before and after Covid-19.
N Engl J Med. 2024;390:863-865.
Nature
- CARLSON C, Becker D, Happi C, O'Donoghue Z, et al
Save lives in the next pandemic: ensure vaccine equity now.
Nature. 2024;626:952-953.
- JAMOULLE M, Louazon E, Antonacci T, Van Weyenbergh J, et al
Speed up relief for long COVID through grassroots clinical trials.
Nature. 2024;626:954.
Science
- AL-ALY Z, Topol E
Solving the puzzle of Long Covid.
Science. 2024;383:830-832.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016